Reviewed profile

food and beverage brand · public preview

Rybelsus

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Is this your company?Claim Rybelsus to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Rybelsus — no cold outreach.
Report a changeLog in for full recordLast reviewed 28 Mar 2026 · public preview data

Overview

What Rybelsus covers.

RYBELSUS (semaglutide) is a prescription oral tablet medication indicated for adults with type 2 diabetes. It is used alongside diet and exercise to improve blood sugar control and reduce the risk of major cardiovascular events in high-risk patients. The product is manufactured by Novo Nordisk and represents an oral formulation of the GLP-1 receptor agonist semaglutide.

  • Positioned as a mainstream brand.

FAQ

Questions this page answers.

What does Rybelsus do?

Rybelsus is a food and beverage brand, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.